Literature DB >> 8347612

Specificity studies on the heparin lyases from Flavobacterium heparinum.

U R Desai1, H M Wang, R J Linhardt.   

Abstract

An understanding of the substrate specificity study of the heparin lyases (heparinase and heparitinases) is crucial for elucidation of the sequence of heparin and heparan sulfate. Four chemically modified heparins have been used to study the substrate specificity of the three heparin lyases. These modified heparins include the N- and O-desulfated and then specifically N-sulfated or N-acetylated derivatives of heparin and a modified heparin containing L-galactopyranosyluronic acid residues. These chemically modified heparins were degraded to various extents by the three heparin lyases. Differences in degree of sulfation have profound impact on the ease of cleavage of glycosidic linkages. Heparin lyase I (EC 4.2.2.7) is selective in cleaving highly sulfated polysaccharide chains containing linkages to 2-O-sulfated alpha-L-idopyranosyluronic acid residues. Heparin lyase III (EC 4.2.2.8) cleaves linkages that have reduced density of sulfation and that contain beta-D-glucopyranosyluronic acid residues. The ability of heparin lyase III to act on linkages to unsulfated alpha-L-idopyranosyluronic acid residues is observed for the first time. Heparin lyase II (no assigned EC number) demonstrates an unparalleled, wide specificity for substrates comprised of linkages containing both alpha-L-idopyranosyluronic and beta-D- glucopyranosyluronic acid residues. Heparin lyase II can also act on substrates containing linkages to unnatural alpha-L-galactopyranosyluronic acid residues. The high level of specificity of heparin lyase I makes it particularly suitable for use in the sequencing of heparin and heparan sulfate, while caution must be exercised in using heparin lyases II and III to sequence heparin and heparan sulfate because of their relatively broad specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347612     DOI: 10.1021/bi00083a012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.

Authors:  Zhongping Xiao; Wenjing Zhao; Bo Yang; Zhenqing Zhang; Huashi Guan; Robert J Linhardt
Journal:  Glycobiology       Date:  2010-08-20       Impact factor: 4.313

3.  Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Bo Yang; Lingyun Li; Fuming Zhang; Changhu Xue; Robert J Linhardt
Journal:  Anal Biochem       Date:  2014-03-28       Impact factor: 3.365

4.  Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry.

Authors:  Youjin Seo; Armann Andaya; Julie A Leary
Journal:  Anal Chem       Date:  2012-02-14       Impact factor: 6.986

5.  Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue.

Authors:  Wenjing Zhao; Marie-Line Garron; Bo Yang; Zhongping Xiao; Jeffrey D Esko; Miroslaw Cygler; Robert J Linhardt
Journal:  FEBS Lett       Date:  2011-07-06       Impact factor: 4.124

6.  Delineating mechanisms of dissociation for isomeric heparin disaccharides using isotope labeling and ion trap tandem mass spectrometry.

Authors:  Ola M Saad; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2004-09       Impact factor: 3.109

7.  Conformational flexibility of PL12 family heparinases: structure and substrate specificity of heparinase III from Bacteroides thetaiotaomicron (BT4657).

Authors:  ThirumalaiSelvi Ulaganathan; Rong Shi; Deqiang Yao; Ruo-Xu Gu; Marie-Line Garron; Maia Cherney; D Peter Tieleman; Eric Sterner; Guoyun Li; Lingyun Li; Robert J Linhardt; Miroslaw Cygler
Journal:  Glycobiology       Date:  2016-09-12       Impact factor: 4.313

8.  Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.

Authors:  Derek J Langeslay; Consuelo N Beecher; Annamaria Naggi; Marco Guerrini; Giangiacomo Torri; Cynthia K Larive
Journal:  Anal Chem       Date:  2012-12-31       Impact factor: 6.986

9.  Differentiation of 3-O-sulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif.

Authors:  John K Meissen; Matthew D Sweeney; Matthew Girardi; Roger Lawrence; Jeffrey D Esko; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2008-12-09       Impact factor: 3.109

10.  Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virus.

Authors:  Wuyang Zhu; Lihua Wang; Yiliang Yang; Juan Jia; Shihong Fu; Yun Feng; Ying He; Jin-Ping Li; Guodong Liang
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.